Novo Nordisk (NVO.N) rose more than 7% in pre-market trading, on track for its best single-day performance since March 2024.

2025-09-18

Novo Nordisk (NVO.N) rose more than 7% in pre-market trading, on track for its best single-day performance since March 2024.

Other News
2025-09-18

Gold continues to decline, and a correction is expected in the short term. Where should we look for intraday rebounds? The V Assistant Team analyzes market trends in real time. Click here to get private advice from our think tank for the day and rece

2025-09-18

International 1. Fitch: The Federal Reserve is fully committed to supporting employment and will tolerate higher inflation in the short term. 2. Goldman Sachs: Maintaining an overweight position in both A-shares and H-shares, the A-share "slow bull"